Skip to content

Drug interactions

Erdafitinib + Methotrexate

Severity: Moderate

Erdafitinib and Methotrexate: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Erdafitinib can inhibit intestinal and cellular P-glycoprotein, which may raise exposure to methotrexate. Higher methotrexate levels increase the risk of myelosuppression, mucositis and hepatic or renal toxicity.

What this interaction means in plain words

Erdafitinib and Methotrexate can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Erdafitinib belongs to Oncology; Methotrexate belongs to Oncology.

Evidence level: Low

Why it happens

Erdafitinib inhibits P-glycoprotein efflux transport, potentially reducing methotrexate elimination and increasing absorption.

What to do

Monitor blood counts, liver and renal function and signs of methotrexate toxicity if the two are combined. Consider a methotrexate dose reduction if toxicity emerges.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Erdafitinib and Methotrexate, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Erdafitinib with Methotrexate?

MediHelp rates the interaction as moderate. Erdafitinib and Methotrexate can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Erdafitinib can inhibit intestinal and cellular P-glycoprotein, which may raise exposure to methotrexate. Higher methotrexate levels increase the risk of myelosuppression, mucositis and hepatic or renal toxicity.

How serious is the interaction between Erdafitinib and Methotrexate?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts, liver and renal function and signs of methotrexate toxicity if the two are combined. Consider a methotrexate dose reduction if toxicity emerges.

What other medicines interact with Methotrexate?

MediHelp also lists interactions of Methotrexate with, for example, Acitretin, Adenovirus types 4 and 7 live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Methotrexate page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in